RxDoctor Payments DataLook up a doctor →

Angel Chinea, MD

Neurology · Guaynabo, PRNPI 1720029317

Payments from drug & device makers

$13,330,737in general payments, 2019–2025

Across 2,273 payments — averaging $5864.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$10.6M
  • EMD Serono, Inc.$553K
  • Biogen$460K
  • Genentech, Inc.$400K
  • TG Therapeutics, Inc.$285K
  • Genentech USA, Inc.$216K
  • plus $806K from 32 others
$17,694in research payments, 2019–2025

Across 18 payments — averaging $983.03 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$14K
  • Sanofi$3K
  • Eli Lilly$1K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis346$10,610,685
EMD Serono, Inc.426$553,239
Biogen446$460,036
Genentech, Inc.28$399,915
TG Therapeutics, Inc.59$285,042
Genentech USA, Inc.235$216,087
Sanofi141$195,261
AbbVie(2 entities)91$110,002
Bristol Myers Squibb38$92,350
Roche Products Limited13$70,930
Amgen(2 entities)55$61,164
Chugai Pharmaceutical Co., Ltd.19$53,341
AstraZeneca53$44,286
E.r. Squibb & Sons, L.L.C.112$43,365
Merck Kgaa7$25,311
Mallinckrodt Hospital Products Inc.14$23,268
Ares Trading SA10$20,000
Teva Pharmaceuticals USA, Inc.52$19,325
Hoffmann-la Roche Limited5$15,921
Banner Life Sciences, LLC13$7,385
Mallinckrodt Enterprises LLC11$7,180
Lilly USA, LLC7$6,975
F. Hoffmann-la Roche AG1$3,991
Johnson & Johnson(2 entities)3$1,722
Alphatec Spine, Inc6$1,159
Stryker6$885
ANI Pharmaceuticals, Inc.25$607
PBG Puerto Rico LLC12$254
Biohaven Pharmaceuticals, Inc.11$203
Globus Medical2$159
Biohaven Pharmaceutical Holding Company Ltd.9$145
Imperative Care, Inc1$133
Eli Lilly Export S.A. Puerto Rico Branch7$126
Medtronic1$97
Vanda Pharmaceuticals Inc.3$58
Biocomposites Inc1$55
Lundbeck LLC3$50
Sanofi-aventis U.S. LLC1$25

How this compares

$13,330,737 in reported general payments places this provider in the 95th percentile of 129 neurology providers in Puerto Rico.

See all neurology providers in Puerto Rico →

Medicare billing

Part B allowed, 2024
$45,478
Medicare patients
55
Services billed
5,302

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Guaynabo

See the full list for Puerto Rico →

Where these figures come from

Is this you, or does something look wrong? →